Errasti-Murugarren E - Search Results

1

The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs.

Errasti-Murugarren E, Molina-Arcas M, Casado FJ, Pastor-Anglada M. Errasti-Murugarren E, et al. Mol Pharmacol. 2010 Aug;78(2):157-65. doi: 10.1124/mol.110.063552. Epub 2010 Apr 26. Mol Pharmacol. 2010. PMID: 20421346

2

Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling.

Pastor-Anglada M, Errasti-Murugarren E, Aymerich I, Casado FJ. Pastor-Anglada M, et al. J Physiol Biochem. 2007 Mar;63(1):97-110. doi: 10.1007/BF03174089. J Physiol Biochem. 2007. PMID: 17722647 Review.

3

SLC28 genes and concentrative nucleoside transporter (CNT) proteins.

Pastor-Anglada M, Cano-Soldado P, Errasti-Murugarren E, Casado FJ. Pastor-Anglada M, et al. Xenobiotica. 2008 Jul;38(7-8):972-94. doi: 10.1080/00498250802069096. Xenobiotica. 2008. PMID: 18668436 Review.

4

Role of CNT3 in the transepithelial flux of nucleosides and nucleoside-derived drugs.

Errasti-Murugarren E, Pastor-Anglada M, Casado FJ. Errasti-Murugarren E, et al. J Physiol. 2007 Aug 1;582(Pt 3):1249-60. doi: 10.1113/jphysiol.2007.130138. Epub 2007 Apr 5. J Physiol. 2007. PMID: 17412768 Free PMC article.

5

Functional characterization of a nucleoside-derived drug transporter variant (hCNT3C602R) showing altered sodium-binding capacity.

Errasti-Murugarren E, Cano-Soldado P, Pastor-Anglada M, Casado FJ. Errasti-Murugarren E, et al. Mol Pharmacol. 2008 Feb;73(2):379-86. doi: 10.1124/mol.107.041848. Epub 2007 Nov 9. Mol Pharmacol. 2008. PMID: 17993510

6

A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum.

Errasti-Murugarren E, Molina-Arcas M, Casado FJ, Pastor-Anglada M. Errasti-Murugarren E, et al. FASEB J. 2009 Jan;23(1):172-82. doi: 10.1096/fj.08-113902. Epub 2008 Sep 30. FASEB J. 2009. PMID: 18827020

7

Drug transporter pharmacogenetics in nucleoside-based therapies.

Errasti-Murugarren E, Pastor-Anglada M. Errasti-Murugarren E, et al. Pharmacogenomics. 2010 Jun;11(6):809-41. doi: 10.2217/pgs.10.70. Pharmacogenomics. 2010. PMID: 20504255 Review.

8

Different N-terminal motifs determine plasma membrane targeting of the human concentrative nucleoside transporter 3 in polarized and nonpolarized cells.

Errasti-Murugarren E, Casado FJ, Pastor-Anglada M. Errasti-Murugarren E, et al. Mol Pharmacol. 2010 Nov;78(5):795-803. doi: 10.1124/mol.110.065920. Epub 2010 Jul 19. Mol Pharmacol. 2010. PMID: 20643903

9

Expression and distribution of nucleoside transporter proteins in the human syncytiotrophoblast.

Errasti-Murugarren E, Díaz P, Godoy V, Riquelme G, Pastor-Anglada M. Errasti-Murugarren E, et al. Mol Pharmacol. 2011 Nov;80(5):809-17. doi: 10.1124/mol.111.071837. Epub 2011 Aug 8. Mol Pharmacol. 2011. PMID: 21825094

10

Functional analysis of the human concentrative nucleoside transporter-1 variant hCNT1S546P provides insight into the sodium-binding pocket.

Cano-Soldado P, Gorraitz E, Errasti-Murugarren E, Casado FJ, Lostao MP, Pastor-Anglada M. Cano-Soldado P, et al. Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C257-66. doi: 10.1152/ajpcell.00198.2011. Epub 2011 Oct 12. Am J Physiol Cell Physiol. 2012. PMID: 21998139 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters